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Abstract 
 This paper will report on research which aims to generate bone replacement components by 
processing bioactive glass-ceramic powders using indirect selective laser sintering.  The indirect 
SLS route has been chosen as it offers the ability to tailor the shape of the implant to the 
implantation site, and two bioactive glass ceramic materials have been processed through this 
route: apatite-mullite and apatite-wollostanite. The results of bend tests, to investigate 
mechanical properties, and in vitro and in vivo experiments to investigate biological responses of 
the materials will be reported, and the suitability of completed components for implant will be 
assessed.   
 
1. Introduction 
 A wide range of researchers have identified the potential for layer manufacture systems to 
deliver implants which are personally tailored to the individual patient, and which have been 
created in materials which will interact positively with the body (rather than be biologically 
inert).  State of the art commercially in this area is Therics™ [1].   Therics™ manufacture, using 
3D printing layer manufacture technology, a range of bone grafts and bone void fillers.  The 
layer manufacture technology is not used to create bone void fillers which conform directly to 
the void shape, but it is used to create complex internal architectures in a small range of products,  
with structured internal porosity to support bone ingrowth and subsequent vascularisation [2].    
The materials used by Therics™ are resorbable (and so over time they will be broken down by 
the body and replaced with natural bone) and are based on hydroxyapatite and tricalcium-
phosphate materials held in a polymer matrix.   
 
 The ability to develop their approach to create personalised shapes is something which 
Therics™ may develop in the future.  In the research arena a number of research groups have 
examined the scope for the creation of bone replacements or tissue engineering scaffolds, with 
the tissue engineering scaffolds aimed at both hard and soft tissues.  The tissue engineering 
scaffold approach operates through first creating a structure (the scaffold) and then seeding this 
structure in vitro with stem cells and proteins.  The stem cells will then proliferate and 
differentiate into the required type of cell whilst secreting the extracellular matrix required to 
create the type of tissue needed.  Once the type of tissue desired has been created implantation 
occurs.   
 
 Much of the work aimed at producing tissue engineering scaffolds has looked to exploit a 
range of layer manufacturing techniques to create scaffolds in resorbable polymers, notably poly-
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(ε-caprolactone) [3,4], poly(L)lactide (PLA) [5], and poly(propylene fumarate) [6].  In addition a 
number of polymer-ceramic composite materials have been fabricated, using PLA and 
hydoxyapatite [5], and poly (D,L-lactide-co-glycolide) and tricalcium phosphate [7].  
Hydroxyapatite and tricalcium phosphate are both bioceramics, and so by definition have 
chemical compositions close to the mineral content of bone, and their use together with 
resorbable polymers seeks to create a more biomimetic material, as bone itself can be considered 
to be a polymer/ceramic (collagen/calcium phosphate) composite [8].  Collagen itself has also 
been used with layer manufacture methods to create a tissue engineering scaffold [9].  Collagen 
is a natural hydrogel (a colloidal gel in which water is the dispersion medium) and this has 
inspired work with other hydrogel materials [10].  In all of the cases where tissue engineering 
scaffolds have been created using layer manufacture methods the ability of the layer manufacture 
techniques to (i) create biomimetic architectures, and (ii) create a scaffold which can be adapted 
to a required geometry, have been cited as major advantages of the routes.   
 
 A number of researchers have also investigated processing bioceramics for bone replacement 
and tissue engineering applications [11,12], and our work in this area has focussed on processing 
bioceramics, in particular apatite-mullite (A-M) and apatite-wollostonite (A-W), with bone 
replacement or hard tissue engineering scaffolds the intended application areas.  Initial studies 
[13] were based on direct SLS, but indirect approaches have proved more capable in terms of 
delivery of coherent components [14].  This paper outlines recent research outcomes for both A-
M and A-W, with reference to both mechanical and biological properties. 
 
2. Processing Routes 
 The bioceramic powders have been produced within the Leeds Dental Institute, using a melt 
quenching technique [15,16].  For both A-M and A-W the glass frit using this technique has then 
been ground to a powder and sieved to give a range of particle sizes.  Powder with particles in 
the range 45-90µm have been used for SLS, offering the best play-off between ease of spreading 
in manufacture and the definition of the green parts produced.  In some cases a mixture of 45-
90µm size powder and 0-45µm powder has been used to increase the bed density.  Prior to 
processing the powders have been mixed with 5% by volume of a powder acrylic binder.  5% 
binder has been found to be the minimum level of binder which results in green parts which are 
capable of being handled without damage occurring in the green stage.  The SLS stage was 
carried out on an experimental SLS machine at the University of Leeds, which has a 250W CO2 
laser, and is fully described elsewhere [15].  In the laser sintering stages a wide processing 
window is available with indirect SLS, with laser powers ranging up to 60W, and scan speeds of 
up to 800mm/s.  Table 1 summarises the processing conditions used with each of the two 
materials to create green parts.  SLS was carried out in an air atmosphere.   
 
 Once the green parts have been created the next stage in the process is to post-process the 
components through a heat treatment to burn off the binder, sinter the powder particles, and 
evolve the required microstructure.  In developing a heat treatment for the A-W material the 
approach taken was to identify the optimum nucleation temperature (ONT), as this is the 
temperature at which a hold in the heat treatment is desirable in order to allow the maximum 
number of nuclei to form, such that high levels of crystallisation occur.  A further temperature 
hold after nucleation is required to promote crystal growth. The temperature for this 
crystallization treatment was selected on the basis of DTA analyses to favour the crystal 
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propagation of apatite and wollastonite simultaneously [16].  This process resulted in the post-
processing regime shown in Figure 1. 
 
 
Material 
Laser  
Power (W) 
Beam Diameter 
at Bed (mm) 
Scan Speed 
(mm/s) 
Scan 
Overlap (%) 
Depth of Spread 
Layers (mm) 
A-M 12 1.1 150 50 0.25 
A-W 5 0.55 150 50 0.125 
 
Table 1 – Processing Conditions 
Time
Temperature
779°C
1 hour
10K/min
10K/min
cool down
1150°C
1 hour
Optimum 
Nucleation
Crystals 
Growth
room 
temperature
 
Figure 1 – A-W Heat Treatment Regime 
 
 A similar approach was initially taken to the development of a heat treatment regime for the 
A-M material, but proved unable to create components with any significant strength.  For the A-
M material it appears that the nucleation process removes too much of the glassy phase of the 
material, and, as it is the glassy phase which provides the material for liquid phase sintering, this 
produced components with very low strengths.  The solution to this problem was to use a heat 
treatment which involved putting the green parts directly into a furnace at 1200ºC, holding at this 
temperature for an hour and then cooling at the natural rate of the furnace.  When the material is 
placed directly into a very hot furnace there appears to be enough time for liquid phase sintering 
to occur before crystallisation, hence stronger parts can be produced. 
 
 After sintering the A-M and A-W components were 50-60% dense, and had open porous 
structures favourable for bone ingrowth and vascularisation.  Figure 2 shows a comparison the of 
microstructures before and after heat treatment of A-W.  The pores are relatively small, but 
macroporosity can clearly be created at the SLS stage.  A-M showed a very similar response.  
For some components further post-processing was undertaken in order to infiltrate the 
components with phosphate glass.  The aim in doing this was to increase the strength of the 
components, and to increase the bioactivity through offering a combination of two bioactive 
phases.  The infiltration was carried out by placing phosphate powder on top of a sintered part 
within a vacuum furnace, then heating at 10ºC/min to 1200ºC, holding at that temperature for an 
hour, and cooling at the natural rate of the furnace.  The infiltration process produced parts in 
which the porosity had been almost completely eliminated. 
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(b) (a) 
  
Figure 2 – (a) A-W Green Part, (b) A-W Brown Part 
 
3. Mechanical Properties 
 The mechanical properties of the components have been investigated using three point bend 
tests.  Specimens nominally 25mm x 4mm x 3mm or 20mm x 3mm x 3mm were produced 
according to the processing conditions described above, with the span in the bend test either 
20mm or 15mm depending on the original length of the sample.  All the tests were carried out at 
room temperature and the speed of the moving support was 2mm/s.  The peak force recorded 
was used to calculate the flexural strength (σ) from [17];- 
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ab
Pl=σ   (1) 
where P is the loading force, l is the span of two parallel roller supports, a is the width of sample, 
and b is the thickness of sample.    
 
 Figure 3 shows a summary of the measured flexural strengths of samples produced using the 
materials and processing conditions outlined above, together with the commonly quoted 
strengths of  cancellous and cortical bone [18].   The results show from a baseline figure of 
7MPa for A-M that mixing the 45-90µm A-M with a proportion of finer powder, or infiltrating 
with a phosphate glass approximately doubles the strength, to the stage where it is in line with 
that of cancellous bone. The use of mixed powder size ranges still leaves significant porosity 
(~40%), and so there is scope to combine these approaches to gain a further improvement in 
strength.  The A-W material is stronger than the A-M material even before any strategies to 
increase its strength have been implemented, and current work is seeking to employ similar 
methods to those used with the A-M material to drive the A-W material strength up towards that 
of cortical bone. 
 
4. Biological Responses 
 
4.1 In Vitro – Simulated Body Fluid 
 The first in vitro approach used relies upon the observation that a prerequisite for an artificial 
material to bond to bone is the formation of a bone-like apatite layer on its surface when 
implanted into a bony defect.  This same type of apatite layer can be observed on the surfaces of 
bioactive glasses and glass-ceramics when they are exposed to a simulated body fluid (SBF) [19], 
and SBF testing is a method of assessing how well bone replacements would be expected to bond 
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to bone upon implantation. Figure 4 shows the results of an SBF study on samples of A-W 
produced by indirect SLS, showing that apatite forms on this material very quickly, and that after 
14 days a layer which completely covers the A-W material has formed (shown at the top of 
Figure 4(d), with the A-W at the bottom).  These results are extremely positive.  As bone growth 
occurs quickly the rapid formation of the apatite layer means that natural bone in vivo would 
have material which it could bond directly to within a short time of implantation, which would 
promote bonding as against fibrous encapsulation [15].  This would offer very rapid and natural 
fixation of an implant, allowing patient mobility to be restored as early as possible after surgery. 
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Figure 3 – Summary of Flexural Strength Test Results. 
Error bars indicate full range of strengths measured or reported. 
 
4.2 In Vitro – Stem Cell Seeding 
 This set of tests is the first of a series aimed at understanding how well A-W produced using 
indirect SLS will act as a tissue engineering scaffold.  Laser sintered A-W samples with 
dimensions approximately 3mm x 3mm x 2mm seeded with human mesenchymal stem cells 
(MSCs).  MSCs were extracted from the marrow of femoral heads obtained from routine hip 
replacement surgery following informed consent.  MSCs are multipotent cells that can 
differentiate into bone forming cells (osteoblasts), as well as cartilage and adipose tissues and are 
attractive candidate cells for orthopaedic cell-based therapies. MSCs were statically seeded onto 
A-W scaffolds to asses their ability to attach to the scaffolds surface. To determine the optimal 
cell seeding density MSCs were seeded at different densities of 1 x 105, 5 x 105 and 1 x 106 cells 
per scaffold. The scaffolds were cultured for six hours then analysed for cell attachment by 
scanning electron microscopy and confocal microscopy as shown in Figure 5. For confocal 
analysis the MSCs were labelled with a fluorescent dye (Cell Tracker Green) prior to seeding. 
MSCs successfully attached to and spread on the A-W scaffolds after six hours achieving an 
even coverage of cells over the seeded surface. 
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4.3 In Vivo Test Results 
 For bone replacement materials which have shown promising in vitro behaviour the next 
stage in evaluation is an in vivo evaluation.  Cylindrical samples of A-M glass ceramic, 4mm in 
diameter and 10mm in length were produced by indirect SLS.  The materials were implanted into 
the metaphysic of the tibia of six mature male rabbits using strict aseptic surgical techniques, 
along with samples of commercially available A-W (Cerabone®).  The interface between the 
implanted materials and the surrounding bone four weeks after implantation can be seen in the 
SEM micrographs shown in Figure 6, where the bone is on the left hand side of the images with 
the implants on the right hand side.  The images show that the bone has grown into the porous 
implant structure, and that the bone appears to grow right up to the surface of the implanted 
material.  These results confirm the promise shown by the implant structures in vitro and further 
confirm the excellent bioactive behaviour shown by these materials: to all intents and purposes 
the materials behave in vitro and in vivo as ideal bone implant materials, able to rapidly bond to 
bone and showing the same chemical reactions as one would expect from the apatite phase of 
natural bone. 
 
 
 
 
  
(b)(a) 
(d)(c) 
 
Figure 4 – A-W (a) before SBF testing, (b) and (c) after 1 day immersed in SBF,  
and (d) after 14 days immersed in SBF 
 
5. Conclusions 
• For the A-M material it is clear that the in vivo bioactive behaviour is very promising.  The 
strength of this material as processed by indirect SLS is comparable to that of cancellous 
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bone, indicating that, at this stage, it would be suitable for non-load bearing applications 
within the body. 
• For the A-W material we are at an earlier stage in development.  However, A-W processed 
conventionally is known to exhibit excellent bioactivity, reinforced by Figure 6(b), and the 
SBF and initial stem cell seeding trials show excellent bioactive potential for A-W produced 
by indirect SLS.  At no point in our studies has the processing route changed the bioactive 
response of either of the materials examined.  In addition A-W produced by indirect SLS also 
shows excellent mechanical properties, and we are confident that further processing trials 
will allow us to generate mechanical properties in line with those exhibited by cortical bone. 
(a) (b)
  
Figure 5 –  (a) SEM image of an A-W scaffold 6 hours after seeding with 5x105 MSCs, 
(b) Confocal microscope image of an A-W scaffold 6 hours after seeding with 5x105 MSCs. 
MSCs are fluorescently labelled with Cell Tracker Green. Depth into scaffold is 46µm. 
 
  
(b)(a) 
 
Figure 6 – (a) SEM of implanted A-M material produced by indirect SLS, 
(b) SEM of implanted A-W material. 
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